abrdn Healthcare Investors (NYSE:HQH) Reaches New 52-Week High – What’s Next?

abrdn Healthcare Investors (NYSE:HQHGet Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $19.79 and last traded at $19.51, with a volume of 1022 shares. The stock had previously closed at $19.33.

abrdn Healthcare Investors Stock Performance

The firm’s 50 day simple moving average is $19.10 and its 200-day simple moving average is $18.03.

abrdn Healthcare Investors Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, January 12th. Investors of record on Friday, November 21st were paid a dividend of $0.57 per share. This is a positive change from abrdn Healthcare Investors’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Friday, November 21st. This represents a $2.28 annualized dividend and a yield of 11.7%.

Institutional Trading of abrdn Healthcare Investors

A number of hedge funds have recently made changes to their positions in HQH. Royal Bank of Canada boosted its holdings in shares of abrdn Healthcare Investors by 22.0% in the 1st quarter. Royal Bank of Canada now owns 529,826 shares of the financial services provider’s stock valued at $8,604,000 after buying an additional 95,441 shares during the period. Integrated Wealth Concepts LLC bought a new position in shares of abrdn Healthcare Investors during the first quarter valued at approximately $166,000. NewEdge Advisors LLC raised its position in shares of abrdn Healthcare Investors by 3.0% during the 1st quarter. NewEdge Advisors LLC now owns 43,233 shares of the financial services provider’s stock worth $702,000 after purchasing an additional 1,274 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of abrdn Healthcare Investors by 7.2% in the 1st quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider’s stock worth $191,000 after purchasing an additional 788 shares during the last quarter. Finally, Janney Montgomery Scott LLC boosted its position in abrdn Healthcare Investors by 0.5% during the 2nd quarter. Janney Montgomery Scott LLC now owns 156,361 shares of the financial services provider’s stock valued at $2,422,000 after purchasing an additional 768 shares during the period. Institutional investors and hedge funds own 32.60% of the company’s stock.

abrdn Healthcare Investors Company Profile

(Get Free Report)

abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.

The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.

Read More

Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.